Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Medulloblastoma

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related cancers:

‹

Brain Cancer (583)

Brain Cancer (583)

›

No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	carmustine Sensitive: A1 - Approval carmustine Sensitive : A1	carmustine Sensitive: A1 - Approval carmustine Sensitive : A1
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline cisplatin + cyclophosphamide + vincristine Sensitive : A2	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline cisplatin + cyclophosphamide + vincristine Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline cisplatin + vincristine + lomustine Sensitive : A2	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline cisplatin + vincristine + lomustine Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cyclophosphamide Sensitive: A2 - Guideline cyclophosphamide Sensitive : A2	cyclophosphamide Sensitive: A2 - Guideline cyclophosphamide Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	vismodegib Sensitive: A2 - Guideline vismodegib Sensitive : A2	vismodegib Sensitive: A2 - Guideline vismodegib Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + cyclophosphamide + etoposide IV Sensitive: A2 - Guideline cisplatin + cyclophosphamide + etoposide IV Sensitive : A2	cisplatin + cyclophosphamide + etoposide IV Sensitive: A2 - Guideline cisplatin + cyclophosphamide + etoposide IV Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	temozolomide Sensitive: A2 - Guideline temozolomide Sensitive : A2	temozolomide Sensitive: A2 - Guideline temozolomide Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline cyclophosphamide + etoposide oral Sensitive : A2	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline cyclophosphamide + etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide oral Sensitive : A2	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	CX-4945 Sensitive: B - Late Trials CX-4945 Sensitive : B	CX-4945 Sensitive: B - Late Trials CX-4945 Sensitive : B
PTCH1 mutation	Medulloblastoma	PTCH1 mutation	Medulloblastoma	vismodegib Sensitive: C3 – Early Trials vismodegib Sensitive : C3	vismodegib Sensitive: C3 – Early Trials vismodegib Sensitive : C3